Martins, A.C.; Oshiro, M.Y.; Schiavon, B.N.; de Jesus, G.A.; de la Torre, B.G.; Albericio, F.
Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024. Biomedicines 2025, 13, 1962.
https://doi.org/10.3390/biomedicines13081962
AMA Style
Martins AC, Oshiro MY, Schiavon BN, de Jesus GA, de la Torre BG, Albericio F.
Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024. Biomedicines. 2025; 13(8):1962.
https://doi.org/10.3390/biomedicines13081962
Chicago/Turabian Style
Martins, Alexander C., Mariana Y. Oshiro, Beatriz N. Schiavon, Glaucia A. de Jesus, Beatriz G. de la Torre, and Fernando Albericio.
2025. "Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024" Biomedicines 13, no. 8: 1962.
https://doi.org/10.3390/biomedicines13081962
APA Style
Martins, A. C., Oshiro, M. Y., Schiavon, B. N., de Jesus, G. A., de la Torre, B. G., & Albericio, F.
(2025). Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024. Biomedicines, 13(8), 1962.
https://doi.org/10.3390/biomedicines13081962
